Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
MXCT MaxCyte
- 4.170
- +0.100+2.46%
Close Feb 14 16:00 ET
- 4.170
- 0.0000.00%
Post 16:01 ET
439.86MMarket Cap-12.26P/E (TTM)
4.320High4.100Low538.48KVolume4.100Open4.070Pre Close2.26MTurnover0.56%Turnover RatioLossP/E (Static)105.48MShares5.26052wk High2.06P/B400.05MFloat Cap3.16552wk Low--Dividend TTM95.94MShs Float17.440Historical High--Div YieldTTM5.41%Amplitude2.450Historical Low4.199Avg Price1Lot Size
About MaxCyte Company
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.
Company Profile
SymbolMXCT
Company NameMaxCyte
Listing DateJul 30, 2021
Issue Price13.00
Founded1998
CEOMr. Maher Masoud
MarketNASDAQ
Employees143
Fiscal Year Ends12-31
Address9713 Key West Avenue,Suite 400
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-301-944-1700
Websitehttp://www.maxcyte.com
Company Executives
- Name
- Position
- Salary
- Maher Masoud
- President, Chief Executive Officer and Director
- 890.37K
- Douglas J Swirsky
- Chief Financial Officer and Principal Accounting Officer
- 1.19M
- Thomas M. Ross
- Executive Vice President, Global Sales
- --
- David I. Sandoval
- Senior Vice President, General Counsel and Corporate Secretary
- --
- Dr. Richard H. Douglas, PhD
- Non-Executive Chairman of the Board
- 190.49K
- Cynthia Lynne Collins
- Director
- --
- Stanley Charles Erck
- Independent Director
- 162.24K
- John Joseph Johnston
- Independent Director
- 160.49K
- William Wade Brooke
- Independent Director
- 177.24K
- Patrick J Balthrop Sr
- Independent Director
- 155.49K
- Dr. Yasir B. Al-Wakeel
- Independent Director
- 238.53K
- Rekha Hemrajani, M.B.A.
- Independent Director
- 243.03K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.